Your cart is empty.
Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
- Shop
- Blog
-
About
About Tecan
Investors
Press Center
People
Publications
- Support
- Contact
- Life Sciences
- Diagnostics
- Partnering
- Language
The Blog
Selected category: cancer immunosuppressant drug monitoring
Back to overview
LC-MS/MS immunosuppressant drug monitoring: from promise to reality
By Manuel Bauer
Advances in the treatment of disease, such as the many different types of cancer and cardiac diseases, mean that organ and bone marrow transplantation is on the rise.1 This rise has in turn generated an increased need for accurate immunosuppressant drug (ISD) monitoring. This 3-part blog series will walk you through the challenges of adapting gold standard mass spec methods such as LC-MS/MS for ISD monitoring, and explore ways to avoid the associated pitfalls.